D-1326-2019 Class II Terminated

Recalled by Pharm D Solutions, LLC — Houston, TX

FDA drug recall D-1326-2019 was initiated by Pharm D Solutions, LLC on May 23, 2019 and is designated Class II. Reason for recall: Lack of Sterility Assurance. The recall status is terminated (terminated Feb 5, 2021). Affected quantity: 104 vials.

Recall details

Product Type
Drugs
Report Date
Jun 19, 2019
Initiation Date
May 23, 2019
Termination Date
Feb 5, 2021
Voluntary/Mandated
FDA Mandated
Product Quantity
104 vials

Product description

Human Chorionic Gonadotropin 12,000 IU vials Pharm D. Solutions 1304 South Loop West, Houston, TX 77054, 1-844-263-6846

Reason for recall

Lack of Sterility Assurance.

Distribution pattern

Nationwide within the United States

Code information

Lot #: 01232019:86 Exp. 07/22/2019; 04042019:86 Exp. 10/01/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1326-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1326-2019. Report a data issue: hello@regdatalab.com.